Application of mitochondrial pyruvate carrier blocker UK5099 creates metabolic reprogram and greater stem-like properties in LnCap prostate cancer cells<i>in vitro</i>Yali Zhong, Zhenhe Suo, Jianguo Wen et al.|Oncotarget|2015Cited by 79
MPC1 and MPC2 expressions are associated with favorable clinical outcomes in prostate cancerXiaoli Li, Zhenhe Suo, Yasai Ji et al.|BMC Cancer|2016Cited by 48
ILs-3, 6 and 11 increase, but ILs-10 and 24 decrease stemness of human prostate cancer cells <i>in vitro</i>Dandan Yu, Zhenhe Suo, Yali Zhong et al.|Oncotarget|2015Cited by 24
MtDNA depletion influences the transition of CD44 subtypes in human prostate cancer DU145 cellsXiaoran Li, Zhenhe Suo, Mantas Grigalavicius et al.|Tumor Biology|2017Cited by 1